Oracle’s (ORCL) Overweight Rating Reiterated at Piper Sandler

Piper Sandler reaffirmed their overweight rating on shares of Oracle (NYSE:ORCL – Get Rating) in a research report report published on Friday morning, Benzinga reports. They currently have a $104.00 price objective on the enterprise software provider’s stock.

Several other equities analysts have also commented on the stock. Barclays upped their price objective on shares of Oracle from $81.00 to $85.00 in a report on Friday. KeyCorp upped their price objective on shares of Oracle from $94.00 to $98.00 and gave the stock an overweight rating in a report on Wednesday, January 18th. Evercore ISI upped their price objective on shares of Oracle from $87.00 to $95.00 in a report on Friday. UBS Group increased their target price on shares of Oracle from $75.00 to $87.00 in a report on Friday. Finally, TheStreet upgraded shares of Oracle from a c rating to a b- rating in a report on Thursday, January 26th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of Moderate Buy and a consensus target price of $95.06.

Oracle Trading Up 1.0 %

Shares of NYSE ORCL opened at $84.93 on Friday. Oracle has a 12-month low of $60.78 and a 12-month high of $91.22. The stock has a market cap of $228.99 billion, a PE ratio of 28.03, a P/E/G ratio of 2.66 and a beta of 1.02. The company has a 50-day moving average of $87.67 and a 200 day moving average of $79.21.

Oracle (NYSE:ORCL – Get Rating) last posted its quarterly earnings results on Thursday, March 9th. The enterprise software provider reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.02. Oracle had a net margin of 17.46% and a negative return on equity of 262.40%. The business had revenue of $12.40 billion during the quarter, compared to analysts’ expectations of $12.42 billion. During the same quarter in the prior year, the company posted $0.94 EPS. The business’s revenue for the quarter was up 17.9% on a year-over-year basis. On average, sell-side analysts forecast that Oracle will post 3.95 EPS for the current fiscal year.

Oracle Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, April 24th. Shareholders of record on Tuesday, April 11th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.88%. The ex-dividend date is Monday, April 10th. This is an increase from Oracle’s previous quarterly dividend of $0.32. Oracle’s dividend payout ratio (DPR) is 42.24%.

Insider Buying and Selling at Oracle

In other news, Vice Chairman Jeffrey Henley sold 400,000 shares of the stock in a transaction that occurred on Wednesday, December 14th. The stock was sold at an average price of $82.00, for a total value of $32,800,000.00. Following the completion of the sale, the insider now directly owns 1,792,688 shares of the company’s stock, valued at $147,000,416. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Vice Chairman Jeffrey Henley sold 400,000 shares of the firm’s stock in a transaction on Wednesday, December 14th. The stock was sold at an average price of $82.00, for a total value of $32,800,000.00. Following the completion of the sale, the insider now directly owns 1,792,688 shares in the company, valued at $147,000,416. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Rona Alison Fairhead sold 8,080 shares of Oracle stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $89.82, for a total value of $725,745.60. Following the completion of the sale, the director now owns 11,197 shares of the company’s stock, valued at $1,005,714.54. The disclosure for this sale can be found here. Corporate insiders own 43.70% of the company’s stock.

Institutional Investors Weigh In On Oracle

Several institutional investors have recently bought and sold shares of the company. Investors Research Corp lifted its stake in Oracle by 11.5% during the fourth quarter. Investors Research Corp now owns 1,128 shares of the enterprise software provider’s stock worth $92,000 after purchasing an additional 116 shares during the last quarter. Chemistry Wealth Management LLC lifted its stake in shares of Oracle by 0.4% in the 4th quarter. Chemistry Wealth Management LLC now owns 33,617 shares of the enterprise software provider’s stock valued at $2,748,000 after acquiring an additional 118 shares during the last quarter. Steigerwald Gordon & Koch Inc. increased its holdings in Oracle by 2.3% during the 4th quarter. Steigerwald Gordon & Koch Inc. now owns 5,202 shares of the enterprise software provider’s stock valued at $425,000 after purchasing an additional 119 shares during the period. DGS Capital Management LLC grew its holdings in shares of Oracle by 3.1% during the 4th quarter. DGS Capital Management LLC now owns 3,991 shares of the enterprise software provider’s stock worth $326,000 after acquiring an additional 120 shares during the period. Finally, Profund Advisors LLC grew its holdings in shares of Oracle by 0.7% during the 4th quarter. Profund Advisors LLC now owns 18,416 shares of the enterprise software provider’s stock worth $1,505,000 after acquiring an additional 121 shares during the period. Institutional investors own 40.96% of the company’s stock.

Oracle Company Profile

(Get Rating)

Oracle Corp. engages in the provision of products and services that address all aspects of corporate information technology environments. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers applications, platform, and infrastructure technologies.